Dr. Martine Vanlommel

Active

Private limited companyfounded 2017active for 9 yearsMuntelbeekstraat 9, 3500 Hasselt, BelgiumKBO/BCE: BE 0673.964.413

From the official registers: KBO 9 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Martine Vanlommel has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €253,710 and a net result of €186,457. Equity is growing by about 22% per year across the filed financial years. Its solvency ranks better than 31% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow Report Compare

Dr. Martine VanlommelActiveChecked score 91/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 06-04-2017 Normal situation
Legal form: Private limited company
Registered office: Muntelbeekstraat 9, 3500 Hasselt
Activity: Specialist medical practice NACE 86220and 1 other
Establishment unit: 2.263.113.829 3800 Sint-Truiden, since 06-04-2017
Financial year end: 31 December
Peppol: Reachable since 17-12-2025

Company details

Who decides

Board

Martine VANLOMMELDirector · since 16-12-2022

Board & ownership

How it is doing

91 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.1%

Annual accounts 2025

Gross margin: €275,177; ▼ 5.9%
Turnover: ≈ €420,000; estimated
Profit: €186,457; ▼ 5.4%
Equity: €253,710; ▼ 48.5%
Total assets: €669,373; ▼ 7.4%

2025 accounts 106 days early

Filed on 16-04-2026PDF

Financials

Why 91raises riskLiquidity: current ratio 1.22, cash €6,596, halvedlowers riskSector: Human health activities (NACE 86)Size: total assets €669,373Figures for financial year 2025 (filed 16-04-2026)Show the evidence

Checked score

Score 2025

91 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 32% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 63-30

equity 37.9% of total assets

Liquidity 19-66

short-term debt 61.7% · cash 1.0%

Profitability 100=

return on assets 27.9%

Bankruptcy probability, 12 months

0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: 0.1%▲ +0.1 percentage points vs 04-2026highest value 06-2026: 0.1%● unchanged vs 05-2026highest value 07-2026: 0.1%● unchanged vs 06-2026highest value 08-2026: 0.1%● unchanged vs 07-2026highest value 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026

Credit of up to €23,000 on 30-day terms is acceptable

Liquidity tight (current ratio 1.22, compared with 2.37 in 2024, below the usual 1.5; short-term debt: 61.7% and cash: 1% of total assets), and 62.1% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 31% on solvency, 3% on liquidity, 80% on profitability and 13% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

Liquidity: current ratio 1.22, cash €6,596, halved

NBB · annual accounts

Sector: Human health activities (NACE 86)

KBO

Size: total assets €669,373

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Figures for financial year 2025 (filed 16-04-2026)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-04-2026, 106 days ahead of the deadline.

NBB · 9 filings

Deviation from the deadline

2025

106 days early

2024

108 days early

2023

34 days early

2022

34 days early

2021

30 days early

2020

36 days early

2019

38 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 55 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 June (4 of the last 5 filed years within 72 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Caution: Equity fell in 2025from €492,253 to €253,710 ▼ 48.5% View
Positive: Among the best 14% on net resultsector median €60,106 · 20,646 companies €186,457 View
Positive: 8 profitable years in a rowprofit 2025: €186,457 8 years View
Positive: Filed on time since financial year 2019accounts within the deadline every year 7 years View

Documents

Key facts about Dr. Martine Vanlommel

What is the company number of Dr. Martine Vanlommel?: 0673.964.413. In Belgium the VAT number is the company number with BE in front: BE 0673.964.413.
Where is Dr. Martine Vanlommel based?: The registered office is at Muntelbeekstraat 9, 3500 Hasselt.Company details
What does Dr. Martine Vanlommel do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Martine Vanlommel?: Private limited company (BV).
When was Dr. Martine Vanlommel founded?: On 06-04-2017.
Is Dr. Martine Vanlommel still active?: Yes, Dr. Martine Vanlommel is an active enterprise in the KBO register.
How many employees does Dr. Martine Vanlommel have?: On average 0.2 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
What is the turnover of Dr. Martine Vanlommel?: ≈ €420,000 in financial year 2025. Estimated from the gross margin of €275,177: probably between €380,000 and €530,000, based on 36 comparable companies, NACE 862.
Is Dr. Martine Vanlommel profitable?: In financial year 2025, Dr. Martine Vanlommel made a profit of €186,457.
Where can I find the annual accounts of Dr. Martine Vanlommel?: Dr. Martine Vanlommel filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Dr. Martine Vanlommel due?: By 31-07-2027, for financial year 2026.Timeline